Loading clinical trials...
Loading clinical trials...
Development of HER-2/Neu (HER2) ICD Memory Immunity After Vaccination With a Plasmid Encoding HER2 ICD in Patients With Advanced Stage HER2 Overexpressing Breast and Ovarian Cancers
Conditions
Interventions
HER-2/neu intracellular domain protein
flow cytometry
+3 more
Locations
2
United States
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Seattle, Washington, United States
Tumor Vaccine Group at the University of Washington
Seattle, Washington, United States
Start Date
April 1, 2006
Primary Completion Date
March 1, 2010
Completion Date
March 1, 2010
Last Updated
April 5, 2017
NCT04541381
NCT05468034
NCT03137095
NCT07547774
NCT06393374
NCT07040891
Lead Sponsor
University of Washington
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions